• Prescribing information
• Medical Guide

Please note that TRYVIO has a boxed warning for EMBRYO-FETAL TOXICITY

• Prescribing information
• Medical Guide

Review infographics, listen to podcasts, watch videos, or peruse publications on our innovative compounds. 

• Daridorexant
• Aprocitentan

Review infographics ranging from the burden of disease, listen to podcasts on treatment of our target disease areas, and watch videos from KOLs on disease identification and management. 

• Insomnia
• Systemic hypertension

Review information on  how to apply for grants, sponsorships, or support for investigator-sponsored studies.

• Read more

Find out where we will be attending and presenting at upcoming congresses and events as well as review scientific posters or presentations we delivered at past events. 

• Find out more

• Report an adverse event
• File a product quality complaint
• Submit a medical information inquiry

Idorsia is reaching out for more – we have more passion for science, we see more opportunities, and we want to help more patients.
The purpose of Idorsia is to challenge accepted medical paradigms, answering the questions that matter most.
To achieve this, we will discover, develop, and commercialize transformative medicines – either with in-house capabilities or together with partners – and evolve Idorsia into a leading biopharmaceutical company, with a strong scientific core.

Here, we provide the most-up-to-date scientific information regarding our products and therapeutic areas.

If you need to contact us regarding adverse events, product quality complaint, or request medical information for any of our products, please call the number below to fill out the appropriate form.